Placeholder Banner

BIO CEO & Investor Conference Succeeds in Bringing Innovators to Investors and Vice Versa

February 14, 2017
The 19th Annual BIO CEO & Investor Conference came to a close February 14, having drawn more than 1,225 attendees including nearly 500 investors. During a busy two days, over 2,650 partnering meetings took place arranged through BIO’s One-on-One Partnering™—a proprietary system that enables participants to move efficiently from prospective partner identification to discussion and negotiation. Held at the Waldorf Astoria in New York, the event is one of the largest investor conference focused on established and emerging publicly traded and select private biotech companies who are developing the next generation of medicines and cures.

Beyond bringing investors and companies together for potential collaborations and funding opportunities, the conference featured a wide variety of panel discussions and “fireside chats” with CEOs developing innovative therapies to help patients. Professionals from all areas of biotechnology participated including the investment community, C-level biotech executives, patient advocacy and other non-profit organizations, academics and public policy experts.

There were also more than 160 company presentations from established public and private biotech companies on their latest therapies in development. Rounding out the conference program were video-taped interviews with recognized leaders at the BIO Buzz Center. Click here to view the videos or tune into BIO’s YouTube channel.

BIO sponsors meetings and conferences throughout the year that support industry-wide success including the BIO International Convention which attracts roughly 16,000 attendees from around the globe. This year’s event will be held in San Diego, CA June 19-22.